BioDelivery Sciences International, Inc.

BDSI · NASDAQ
Analyze with AI
12/31/2021
9/30/2021
6/30/2021
3/31/2021
Operating Activities
Net Income$63,890$6,669$9,064$5,237
Dep. & Amort.$2,065$1,836$1,769$1,754
Deferred Tax-$55,701$401$330$369
Stock-Based Comp.$1,144$1,837$1,697$1,490
Change in WC$2,618-$3,860-$3,699$2,161
Other Non-Cash-$268$79$69$86
Operating Cash Flow$13,748$6,962$9,230$11,097
Investing Activities
PP&E Inv.$415$0-$119-$296
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$416$0$0-$296
Investing Cash Flow-$1-$6,456-$119-$296
Financing Activities
Debt Repay.$0-$20,000$0$0
Stock Issued$463$0$0$0
Stock Repurch.$11,903$0-$5,756-$6,147
Dividends Paid$0$0$0$0
Other Fin. Act.-$148$351$62$198
Financing Cash Flow-$148-$19,649-$5,694-$5,949
Forex Effect$0$0$0$0
Net Chg. in Cash$13,599-$19,143$3,417$4,852
Supplemental Information
Beg. Cash$100,710$119,853$116,436$111,584
End Cash$114,309$100,710$119,853$116,436
Free Cash Flow$14,163$6,962$9,111$10,801
BioDelivery Sciences International, Inc. (BDSI) Financial Statements & Key Stats | AlphaPilot